Patients in OAC3 represent those with severe eosinophilic T2 asthma and have a similar comparative enrichment of the Woodruff signature as reported previously between the eosinophilic TAC1 and the neutrophilic/inflammasome‐containing TAC2 subjects.14 The gene discussed is TAC1; the disease is asthma.